VEA
LEGN icon

Virtus ETF Advisers’s Legend Biotech LEGN Stock Holding History

Virtus ETF Advisers’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-9,852
Closed -$321K – 627
2024
Q4 		$321K Buy
9,852
+2,310
+31% +$95.7K 0.13% 237
2024
Q3 		$368K Hold
7,542
– – 0.17% 210
2024
Q2 		$334K Buy
7,542
+1,335
+22% +$61.6K 0.16% 205
2024
Q1 		$348K Buy
6,207
+893
+17% +$53.9K 0.19% 212
2023
Q4 		$320K Buy
5,314
+905
+21% +$57.4K 0.2% 217
2023
Q3 		$296K Sell
4,409
-573
-12% -$39.8K 0.18% 201
2023
Q2 		$344K Sell
4,982
-956
-16% -$62.5K 0.2% 160
2023
Q1 		$286K Buy
5,938
+106
+2% +$5.18K 0.16% 244
2022
Q4 		$291K Buy
5,832
+481
+9% +$23.3K 0.15% 282
2022
Q3 		$218K Buy
5,351
+77
+1% +$3.61K 0.09% 311
2022
Q2 		$290K Buy
5,274
+2,079
+65% +$87.8K 0.11% 267
2022
Q1 		$116K Sell
3,195
-189
-6% -$7.47K 0.05% 275
2021
Q4 		$158K Sell
3,384
-1,881
-36% -$95.4K 0.06% 330
2021
Q3 		$266K Sell
5,265
-266
-5% -$11.1K 0.12% 211
2021
Q2 		$227K Sell
5,531
-4,485
-45% -$152K 0.09% 255
2021
Q1 		$291K Buy
10,016
+182
+2% +$4.96K 0.12% 245
2020
Q4 		$277K Buy
+9,834
New +$283K 0.12% 256

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Virtus ETF Advisers's LEGN Position: Q1 2025 in Review

Virtus ETF Advisers sold out of Legend Biotech (LEGN) in Q1 2025, closing a stake of 9,852 shares — an estimated $321K sold.

Virtus ETF Advisers first reported a position in LEGN in Q4 2020 and held it in 17 quarters. The position peaked at $368K in Q3 2024. 208 funds tracked by Wall St. Rank hold LEGN as of Q1 2025.

  • Virtus ETF Advisers reported no remaining Legend Biotech position as of Q1 2025 after selling out during the quarter.
  • Virtus ETF Advisers sold 9,852 Legend Biotech shares in Q1 2025, an estimated $321K.
  • Virtus ETF Advisers first reported a position in Legend Biotech in Q4 2020 and held it in 17 quarters.
  • Virtus ETF Advisers's Legend Biotech position peaked at $368K in Q3 2024.
  • 208 funds tracked by Wall St. Rank held Legend Biotech as of Q1 2025.

Based on Virtus ETF Advisers's 13F filing for Q1 2025, filed 14 May 2025.